Bio-Techne Corp. stock outperforms competitors despite losses on the day
Shares of Bio-Techne Corp. TECH slipped 1.78% to $59.98 Tuesday, on what proved to be an all-around favorable trading session ...
Bio-Techne highlights advances in detection of biomarkers using RNAscope
Corporation announced further advancements in its ongoing strategy to bring translational discoveries to patient care by ...
2 High-Flying Stocks to Target This Week and 1 to Brush Off
Expensive stocks often command premium valuations because the market thinks their business models are exceptional. However, ...
Bio-Techne Corp. stock underperforms Wednesday when compared to competitors
The stock's fall snapped a three-day winning streak.
Bio-Techne To Highlight Advances In The Detection Of Clinically Relevant Biomarkers Using Rnascope Technologies At The 2025 USCAP Annual Meeting
Dr. Gregory Bean, Associate Professor of Pathology at Stanford University, will describe the direct detection of mRNA from CRTC1/3::MAML2 translocations, as alternatives to MAML2 FISH, in the ...
Bio-Techne Co. (NASDAQ:TECH) Receives $82.14 Average Target Price from Analysts
Shares of Bio-Techne Co. (NASDAQ:TECH – Get Free Report) have been given a consensus rating of “Moderate Buy” by the eight ...
Fintel on MSN7d
Evercore ISI Group Initiates Coverage of Bio-Techne (TECH) with Outperform Recommendation
Fintel reports that on March 18, 2025, Evercore ISI Group initiated coverage of Bio-Techne (NasdaqGS:TECH) with a Outperform ...
Bio-Techne price target lowered to $90 from $95 at Argus
Argus analyst David Toung lowered the firm’s price target on Bio-Techne (TECH) to $90 from $95 and keeps a Buy rating on the shares after its ...
American Association of Individual Investors7d
Which Is a Better Investment, Repligen Corporation or Bio-Techne Corporation Stock?
Learn more about whether Repligen Corporation or Bio-Techne Corporation is a better investment based on AAII's A+ Investor ...
Nasdaq26d
Bio-Techne to Present at Investor Conferences
A live webcast of the presentations can be accessed via the IR Calendar page of Bio-Techne's Investor Relations website at https://investors.bio-techne.com/ir ...
Evercore ISI Initiates Coverage on Bio-Techne (NASDAQ:TECH)
Equities research analysts at Evercore ISI assumed coverage on shares of Bio-Techne (NASDAQ:TECH – Get Free Report) in a ...
The Victoria Advocate1d
Bio-Techne to Highlight Advances in the Detection of Clinically Relevant Biomarkers using RNAscope Technologies at the 2025 USCAP Annual Meeting
MINNEAPOLIS, March 24, 2025 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ: TECH) today announced further advancements in its ongoing strategy to bring translational discoveries to patient care ...